Ronit Simantov - 13 Jun 2024 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Director
Signature
/s/ Nicholas Maestas, Attorney-in-Fact for Ronit Simantov
Issuer symbol
TPST
Transactions as of
13 Jun 2024
Net transactions value
$0
Form type
4
Filing time
14 Jun 2024, 18:05:07 UTC
Previous filing
02 Feb 2024
Next filing
28 Jan 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Stock Option (right to buy) Award $0 +16,000 $0.000000 16,000 13 Jun 2024 Common Stock 16,000 $3.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option will vest in full on the earlier of (i) June 13, 2025, or (ii) the day of the Issuer's 2025 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date.